Preclinical Study
Also known as: animal study · in vivo / in vitro research
A preclinical study tests a compound in cells or tissue (in vitro) or in living animals (in vivo), before or instead of testing it in people.
Preclinical research is the work done before a compound is tried in humans. The FDA describes two types: in vitro studies, done in cells, tissue or isolated molecules, and in vivo studies, done in living animals. Their main regulatory job is to find out whether a compound could cause serious harm, and they must provide detailed information on dosing and toxicity. Studies submitted to support an FDA application follow Good Laboratory Practice rules (21 CFR Part 58).
Preclinical studies also explore whether a compound might work at all: a rodent injury model, for example, might show faster healing in the treated group. The FDA notes that preclinical studies are usually not very large. They are run under controlled lab conditions with doses chosen for the experiment, which is part of why a result in animals is a lead to follow up, not an answer about people.
Why it matters
For many research peptides, preclinical data is most or all of the evidence. BPC-157 is a common example: its published record is mostly animal and cell work. "Well studied in rats" is a different statement from "well studied in people," and DoseCraft's methodology places preclinical findings in the Experimental lane; animal-only data cannot earn the Clinical lane.
Translation from animals to people is uneven. A 2024 umbrella review covering 367 therapies found that 50% advanced from animal studies to any human study, 40% to a randomized trial, and only 5% to regulatory approval, with median times of 5, 7 and 10 years. The same review found 86% agreement between positive animal results and positive human results where both existed. So a positive animal result is a reasonable lead, but most therapies never complete the human testing needed for approval.
How to read a preclinical study
- Identify the system: cell culture, which animal species, and which disease or injury model.
- Check the dose, route and timing. A rat dose in mg/kg is not a human dose: FDA's starting-dose guidance converts animal doses to human-equivalent doses mainly by body surface area rather than body weight, then applies a safety factor.
- Look at group sizes and whether the people scoring outcomes knew which animals were treated.
- Ask whether the result has been repeated by an independent lab, and whether any human study followed.
- Separate what was measured (a tissue marker, a healing score) from the claim being made about people.
Common mistakes
- Converting an animal mg/kg dose to a human dose by multiplying by body weight.
- Treating an effect seen in a dish at a given concentration as proof that an injected dose reaches that concentration in your tissue.
- Reading "no toxicity seen in rats" as "no risk for people."
- Assuming a positive animal result means human trials are underway or likely to succeed.
- Counting many small animal studies as strong evidence without checking whether they come from the same few labs.
Sources
- ReferenceStep 2: Preclinical Research. U.S. Food and Drug Administration, 2018.
- Systematic reviewAnalysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications. PLoS Biol, 2024. PMID 38870090.
- GuidelineGuidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. U.S. Food and Drug Administration (CDER), 2005.
Page updated . How we grade evidence: methodology.
Related Terms
Clinical Trial
A clinical trial is a planned study that tests a drug or other intervention in people under a written protocol, usually run in phases 1 through 4.
Mechanistic Study
A mechanistic study investigates how a compound acts, such as which receptors, pathways or genes it affects, rather than whether it improves health outcomes.
Three-Lane Evidence System
The three-lane evidence system is DoseCraft's method of labeling each claim by the strength of evidence behind it: Clinical, Expert or Experimental.
Anecdotal Report
An anecdotal report is one person's account of what happened after using something, collected without a control group or a set measurement plan.
Look up any peptide term inside DoseCraft Pro
The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.
Start Free Trial